News Center

Home page

Peak Report

News reports

Jiang Xiaomeng: Resonance with Urban Development

Release time:

2021-08-11

"Jinhua daily" reporter Ji junlei

editor's note: in order to celebrate the centenary of the founding of the party, the organization department of the CPC Jinhua municipal Committee, Jinhua daily and Jinhua radio and television headquarters jointly planned and launched a special report on "100 years, 100 party members of all fields and ages in the city were selected in the form of one person, one short article and one micro-video, linking the moving moments that have taken place in the land of Bawu in the century since the founding of the Party. "Jiang Xiaomeng: Resonance with Urban Development at the Same Frequency" is the fourth article in the series of "Spring Tide Surge, Eight Wines First". In an interview with reporters, Jiang Xiaomeng, chairman of the group company, talked freely about personal development and enterprise symbiosis and co-prosperity, and peak development and Jinhua economy resonance and co-development from his more than 8 years of growth experience in peak work.

Based on the development of Jinhua, after the planned economy and the "Cultural Revolution" period, gradually entered the market economy, and there are not many enterprises that have achieved modern development. Jianfeng Group is one of the models. As a veteran enterprise with a history of

years, under the leadership of Jiang Xiaomeng, Jianfeng Group is still full of vigor and vitality. "In the year of Jianfeng

40 , I went from an ordinary front-line worker to the second-generation helmsman of the group, and witnessed its hard work, determined reform, independent innovation, and scientific development." Jiang Xiaomeng, chairman of Zhejiang Jianfeng Group Co., Ltd., said frankly that his personal development and enterprise symbiosis and co-prosperity. 1980

, Jiang Xiaomeng, who had just graduated from Senior high school, entered the then Jinhua County Cement Factory (the predecessor of Jianfeng Group) to work. At that time, Jinhua County Cement Factory was still in the stage of general kiln production line with more than

,500 employees and annual cement production capacity of only ,10 tons. With the spring breeze of reform blowing all over China, the reform of China's state-owned enterprises has gradually started, and the external environment of peak development has undergone profound changes. Du Zihong, then director of the Peak Cement Plant, was keenly aware that the shortage of enterprise factors could be solved through institutional innovation, and the problem of resource constraints of the Peak Group could be solved through horizontal alliances with enterprises of different ownership. "Jianfeng Group increased its cement production capacity by 30

tons through horizontal integration in the mid -1980 s of the last century, which is equivalent to rebuilding

3 Jinhua cement plants." 1987 5 January 15 , Jinhua Cement Factory united a number of enterprises and units to form Jianfeng Cement Group. In Jiang Xiaomeng's view, this is the first step for the peak to adapt to the transformation and upgrading of the internal and external environment, and it is in the forefront of the national cement industry. Soon, Peak Cement became famous in the market inside and outside the province. 1987 6

, Jiang Xiaomeng was selected by the State Council's Poverty Alleviation Leading Group to go to Dafang, Qianxi and other counties in Guizhou Province for technical poverty alleviation to help local cement factories improve product quality and production efficiency.

1993 7 April 28 , Jianfeng Group was listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry and the second listed company in Zhejiang Province, realizing the leapfrog development of Jianfeng Group. After that, Jianfeng Group entered the exploratory stage of diversified development, involving cement, medicine, transportation, electronics, cable and other fields. In 2004 , Jiang Xiaomeng served as the general manager of Jianfeng Group, and in 2007 , he served as the party secretary and chairman of Jianfeng Group. He conducted in-depth research and analysis on the economic situation and the development trend of the peak industry, put forward the management policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and led the enterprise to transform from diversified development to relatively diversified development and innovative development. Prior to this, he successively served as the general manager of Jianfeng Communication Cable Company and the general manager of Jianfeng Pharmaceutical, and has accumulated rich management experience in long-term practice. He has his own ideas about how to steer the big ship of the tip group.

In that year, Jiang Xiaomeng led Jianfeng Group and China Building Materials to integrate the cement sector business. Jianfeng Group, as one of the sponsor shareholders, participated in the establishment of Southern Cement Co., Ltd. and integrated some cement enterprises in the southeast economic zone through mergers and acquisitions and joint reorganization. Zhejiang Jianfeng Cement Co., Ltd., a subsidiary of Jianfeng Group, and Southern Cement Co., Ltd. jointly funded the establishment of Jinhua Nanfang Jianfeng Cement Co., Ltd. At the same time, Jianfeng Group's cement business, in line with the role of market niche, has successively laid out cement enterprises in Hubei, Yunnan, Guizhou and other regions with resources and markets, gradually establishing a leading position in China's cement industry. Jinhua's "peak cement" has become the golden business card of the whole province and even the whole country.

More importantly, Jianfeng Group and Jinhua City Development resonate at the same frequency. "It is no exaggeration to say that in the process of Jinhua's reform and opening up, Jianfeng Group has a leading role and provides a reference model for the development of many local enterprises." Jiang Xiaomeng said that Jianfeng Group has also actively contributed to the construction of Jinhua's urban infrastructure. The cement of Bayi Road, Shuanglong Street, Gymnasium, Jinwu Bridge, Shuanglong Bridge, and the municipal government were all from the city. Peak.

Jianfeng Group has another business that has to be mentioned, namely medicine. "Cement and medicine are two major industries that complement cyclical and non-cyclical, and they are also two carriages that drive the development of Jianfeng Group." While Jianfeng Group crossed the border from cement to medicine, Jiang Xiaomeng was also constantly learning medical knowledge. With this momentum, he obtained the qualification certificate of licensed pharmacist by himself, and was awarded the title of senior engineer at the professor level of pharmaceutical engineering, and became an expert in the field of medicine. At the same time, Jiang Xiaomeng also began to set up a management, R & D and sales team in the pharmaceutical industry, laying a solid foundation for the long-term and stable development of the enterprise. While doing a good job in business management, Jiang Xiaomeng has been working hard and has published more than 73 30 74 papers on new drug research and development and management in various journals at home and abroad over the years.

Under the leadership of Jiang Xiaomeng, Jianfeng Group has established a good long-term cooperative relationship with well-known universities and scientific research institutions such as China Pharmaceutical University and Shanghai Medical Institute, forming a provincial drug research institute, academician expert workstation, A three-in-one medical research and development system of post-doctoral workstations.

2003

, "Jinhua's first 1.1 class of original new drugs-gatifloxacin and its preparation is developed by our peak, but also won the first prize of scientific and technological progress in Zhejiang Province, the R & D team won the honorary title of 'Zhejiang Province Model Collectives'. At present, the company has been granted 52

patents in the field of medicine, including

43 invention patents." When he said this, Jiang Xiaomeng's face was full of pride. Walking on the streets of Jinhua, the peak pharmacy can be seen everywhere, which is the best proof that the enterprise develops products and serves the public. In recent years, Jianfeng Group has benefited from Jiang Xiaomeng's clear understanding and clear strategy, based on cement and medicine, and has continuously created the best performance in history. At present, the total assets of the company have increased by 48 times compared with that before listing, and the net assets have increased by 43 times. In 2019

, Jianfeng Group won the "Gold Quality" Sustainable Growth Award of Listed Companies. While the enterprise has achieved good benefits, he has also been recognized by the society. He has successively won special government allowances from the State Council, "Zhejiang Province's Second Outstanding Builders of Socialism with Chinese Characteristics", Zhejiang Province's outstanding contributions to young and middle-aged experts, and the first "Zhejiang Province" Outstanding Builders of Socialism with Chinese Characteristics in the New Era "and other awards.

2021 is the first year of the "14th Five-Year Plan". In this year's "Two Sessions", carbon peak, carbon neutrality, digital transformation and green development were highlighted. Standing in a new historical window, Jiang Xiaomeng has a preliminary idea for the future development of the peak. In the future, Jianfeng Group will use its advantages in brand, technology, management, and capital to achieve layout optimization, control resources, occupy the market, and become bigger and stronger. At the same time, in the pharmaceutical sector, we will increase the development of new products with high added value, form a product line of antibiotics, cardiovascular and cerebrovascular drugs, safe drugs for infants and young children, antineoplastic drugs and health products, and occupy the forefront of the pharmaceutical industry. Jiang Xiaomeng said that both cement and medicine are closely related to social economy and people's livelihood. Jianfeng Group's extreme pursuit of the two major industries is not only the need of enterprise development, but also the responsibility of exerting enterprise value and benefiting one party.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页